2008 Faculty Publications

Al-Lozi

  1. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL 3rd, Bgio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ. TDP-43 A315% mutation in familial motor neuron disease. Ann Neurol 2008;63:535-538
  2. Armstrong TN, Dale AM, Al-Lozi MT, Franzblau A, Evanoff BA. Median and ulnar nerve conduction studies at the wrist: Criterion validity of the NC-Stat Automated Device. J Occup Environ Med. 2008; 50:758-764

Baloh

  1. Gitcho M*, Baloh RH*, Chakravery S, Mayo K, Norton J, Levitch D, Hatanpaa K, White CL, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate A, Cairns NJ. TDP-43 A315T Mutation in Familial Motor Neuron Disease. Ann Neurol 2008. 63(4):535-8.
    *Authors contributed equally to this work

Bateman

  1. Measuring target effect of proposed disease-modifying therapies in Alzheimer’s disease.
    Bateman RJ, Klunk WE.
    Neurotherapeutics. 2008 Jul;5(3):381-90. Review.
  2. Stable isotope labeling tandem mass spectrometry (SILT): integration with peptide identification and extension to data-dependent scans.
    Elbert DL, Mawuenyega KG, Scott EA, Wildsmith KR, Bateman RJ.
    J Proteome Res. 2008 Oct;7(10):4546-56. Epub 2008 Sep 6.

Brody

  1. D. L. Brody and D. M. Holtzman “Active and Passive Immunotherapy for Neurodegenerative Disorders” Annual Review of Neuroscience 31, 175-93, 2008. (PMC2561172)
  2. K. E. Saatman, A.C. Duhaime, R. Bullock, A. Maas, A. Valadka, G. T. Manley, And Workshop Scientific Team and Advisory Panel Members Including: D.L. Brody, C. Contant, P. Dash, R. Diaz-Arrastia, S. Fertig, A.Gean, C. Goodman, W. Gordon, R. Hayes, R. Hicks, J. Langlois, A. Marmarou, D. Moore, G. Murray, D. Okonkwo, L. Papa, L. Phillips, N. Plesnila, C. Robertson, C. Robertson, J. Sahuquillo, R. Silbergleit , E. Steyerberg, N. Stocchett, E. Teasdale, G. Teasdale, N. Temkin, H.Thompson, K. Tong, Li. Wilson, D. Wright. “Classification of Traumatic Brain Injury for Targeted Therapies” J. Neurotrauma 25, 719-38, 2008.
  3. D.L. Brody, S. Magnoni, K.E. Schwetye, M.L. Spinner, T. J. Esparza, N. Stocchetti, G. J. Zipfel, D. M. Holtzman. Amyloid-β Dynamics Correlate with Neurological Status in the Injured Human Brain, Science 321, 1221-1224, 2008 (NIHMSID # 67864)
  4. Mac Donald, C. L., Schwarze N., Vaishnavi, S. N., Epstein, A. A., Synder, A. Z., Raichle, M. E., Shimony, J. S., Brody, D. L. Verbal Memory Deficit Following Traumatic Brain Injury: Assessment using Advanced MRI Methods Neurology 71 1199-1201, 2008. (PMC2575660)

Brunstrom-Hernandez

  1. Wingert JR, Burton H, Sinclair RJ, Brunstrom JE, Damiano DL: Tactile object recognition and roughness perception in cerebral palsy. Dev. Med. and Child Neurol 2008 Nov 50 (11): 832-838.
  2. Ghasia F, Brunstrom JE, Gordon M, Tychsen L. Frequency and Severity of Visual Sensory and Motor Deficits in Children with Cerebral Palsy: Gross Motor Function Classification Scale Investigative. Investigative Ophthalmology and Visual Science 2008, 49:2 572-580.

Cairns

  1. Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy. Thorpe JR, Tang H, Atherton J, Cairns NJ. J Neural Transm. 2008 Dec;115(12):1661-71. Epub 2008 Oct 31. PMID: 18974920 [PubMed – indexed for MEDLINE]
  2. ALS and FTLD: two faces of TDP-43 proteinopathy. Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. Eur J Neurol. 2008 Aug;15(8):772-80. Review. PMID: 18684309 [PubMed – indexed for MEDLINE]
  3. Neuronal intermediate filament inclusion disease. Cairns NJ. Handb Clin Neurol. 2008;89:443-8. No abstract available. PMID: 18631766 [PubMed – in process]
  4. Interaction of neuritic plaques and education predicts dementia. Roe CM, Xiong C, Miller JP, Cairns NJ, Morris JC. Alzheimer Dis Assoc Disord. 2008 Apr-Jun;22(2):188-93. PMID: 18525294 [PubMed – indexed for MEDLINE]
  5. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Armstrong RA, Lantos PL, Cairns NJ. Neuropathology. 2008 Aug;28(4):351-65. Epub 2008 Apr 23. Review. PMID: 18433435 [PubMed – indexed for MEDLINE]
  6. TAR DNA-binding protein 43 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: a midwest-southwest consortium for FTLD study. Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao G, Hladik C, Mantanona TY, White CL 3rd. J Neuropathol Exp Neurol. 2008 Apr;67(4):271-9. PMID: 18379440 [PubMed – indexed for MEDLINE]
  7. TDP-43 A315T mutation in familial motor neuron disease. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL 3rd, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ.
    Ann Neurol. 2008 Apr;63(4):535-8. PMID: 18288693 [PubMed – indexed for MEDLINE]
  8. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Mukherjee O, Wang J, Gitcho M, Chakraverty S, Taylor-Reinwald L, Shears S, Kauwe JS, Norton J, Levitch D, Bigio EH, Hatanpaa KJ, White CL, Morris JC, Cairns NJ, Goate A. Hum Mutat. 2008 Apr;29(4):512-21. PMID: 18183624 [PubMed – indexed for MEDLINE]
  9. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer’s and Parkinson’s disease.
    Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, Perlmutter JS, O’Donovan MC, Morris JC, Brayne C, Rubinsztein DC, Lovestone S, Thal LJ, Owen MJ, Williams J. Hum Mol Genet. 2008 Mar 1;17(5):759-67. Epub 2007 Dec 6. PMID: 18063669 [PubMed – indexed for MEDLINE]
  10. Neuropathology for the neuroradiologist: plaques and tangles. Wippold FJ 2nd, Cairns N, Vo K, Holtzman DM, Morris JC. AJNR Am J Neuroradiol. 2008 Jan;29(1):18-22. Epub 2007 Oct 9. Review. PMID: 17925367 [PubMed – indexed for MEDLINE]

Clifford

  1. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ, for the CHARTER Group. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008; 65:65-70.
  2. Robertson K, Kopnisky K, Hakim J, Merry C, Nakasujja N, Hall C, Traore M, Sacktor N, Clifford D, Newton C, Van Rie A, Holding P, Clements J, Zink C, Mielke J, Hosseinipour M, Lalloo U, Amod F, Marra C, Evans S, Liner J, on behalf of the second Assessment of NeuroAIDS in Africa Conference Participants. Second assessment of neuroAIDS in Africa. Journal of Neurovirology 2008; 14:89-101.
  3. Simpson DM, Brown S, Tobias J, NGX-4010 C107 Study Group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008; 70:2305-2313.
  4. Clifford D. HIV-associated neurocognitive disease continues in the antiretroviral era. Topics in HIV Medicine 2008; 16:94-98.
  5. Ellis RJ, Marquie-Beck J, Delaney P, Alexander T, Clifford DB, McArthur JC, Simpson DM, Ake C, Collier AC, Gelman BB, McCutchan JA, Morgello S, Grant I, the CHARTER Group. Human immunodeficiency virus protease inhibitors and risk for peripheral neuropathy. Annals of Neurology 2008; 64:566-572.
  6. Best BM, Letendre SL, Brigid E, Clifford DB, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Ellis R, Capparelli EV, Grant I for the CHARTER Group. Low atazanavir concentrations in cerebrospinal fluid. AIDS 2008; in press.
  7. Clifford DB. Natalizumab and PML: a risky business? Gut 2008; 57:1347-1349.
  8. Evans SR, Clifford DB, Kitch DW, Goodkin K, Schifitto G, McArthur JC, Simpson DM. Simplification of the research diagnosis of HIV-associated sensory neuropathy. HIV Clinical Trials 2008; 9:434-439.

Connolly

  1. Gurnett, C.A., Boehm, S. Connolly, AM, Reimschisel, T. Dobbs, MB. Impact of congenital talipes equinovarus etiology on treatment outcomes. Dev Med Child Neurol; 2008; 50:7; 498-502.

Corbetta

  1. Sestieri C., Pizzella V., Cianflone V., Romani G.L., Corbetta M. Sequential activation of human oculomotor centers during planning of visually-guided eye movements: a combined fMRI-MEG study. Frontiers in Human Neurosciences (2008) doi:10.3389/neuro.09.001.2007
  2. Corbetta M., Patel G.H., Shulman G.L. The reorienting system of the human brain: from environment to theory of mind. Neuron (2008) 58, 306-324.
  3. Sylvester C, Jack A.I., Corbetta M., Shulman G.L. Anticipatory suppression of non-attended locations in visual cortex marks target location and predicts perception. Journal of Neuroscience (2008) Jun 25;28(26):6549-56
  4. Sestieri C., Sylvester, C.M., Jack A.I., d’Avossa G., Shulman G.L., Corbetta M Independence of preparatory signals for spatial attention from number of distracters in the visual field. Journal of Neurophysiology (2008) Aug;100(2):829-38
  5. Fair DA, Snyder AZ, Connor LT, Nardos B, Corbetta M Task-Evoked BOLD Responses Are Normal in Areas of Diaschisis After Stroke. Neurorehabil Neural Repair 2008 Sep 16.
  6. Mantini D, Corbetta M, Perrucci MG, Romani GL, Del Gratta C Large-scale brain networks account for sustained and transient activity during target detection. Neuroimage 2008 Aug 28
  7. Bressler S.L., Tang W., Sylvester C.M., Shulman G.L, Corbetta M. Top-down influences in anticipatory visual spatial attention predict task performance. Journal of Neuroscience (2008) 1;28(40):10056-61
  8. Tosoni A., Galati G., Romani G.L., Corbetta M. Sensory-motor mechanisms in human parietal cortex underlie arbitrary visual decisions. Nature Neuroscience (2008) 12:1446-1453

Cross

  1. Naismith RT, Shepherd BJ, Weihl CC, Tutlam NT, Cross AH. Acute and bilateral blindness due to optic neuropathy associated with copper deficiency. Arch Neurol. 2008 (in press)Sun SW, Liang HF, Cross AH, Song SK. Evolving Wallerian Degeneration after Transient Retinal Ischemia in Mice Characterized by Diffusion Tensor Imaging. NeuroImage 2008; 40:1-10
  2. Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, Cohen R, Marinucci LN, Blight AR,and the Fampridine MS-F202 Study Group. Dose comparison trial of sustained-release fampridine in multiple sclerosis. Neurol. 2008; 71: 1134-1141.
  3. McCandless DD, Piccio LA, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS. Pathologic expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am J Pathol 2008; 172: 799-808
  4. Lyons JA, Ramsbottom MJ, Mikesell RJ, Cross AH: B cells limit epitope spreading and reduce severity of EAE induced with PLP peptide in BALB/c mice. J Autoimmunity 2008; 31: 149-155.
  5. Piccio LM, Stark JL, Cross AH: Chronic Calorie Restriction Attenuates Experimental Autoimmune Encephalomyelitis. J Leuk Biol 2008; 84:940-948.
  6. Xu J, Sun S-W, Naismith RT, Snyder AZ, Cross AH, Song S-w: Assessing Optic Nerve Pathology with Diffusion MRI: from Mouse to Human. NMR in Biomedicine 2008 (in press)
  7. Piccio LM, Buonsanti C, Schmidt RE, Rinker J, Panina-Bordignon P, Cella M, Colonna M, Cross AH: Identification of a novel soluble TREM-2 protein in the cerebrospinal fluid in association with central nervous system inflammation. Brain 2008; 131: 3081-3091

Dhar

  1. Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barré syndrome admitted to the intensive care unit. J Neurol Sci 2008; 264: 121-128.
  2. Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care 2008; 8: 253-258.
  3. Dhar R, Diringer MN. The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage. Neurocrit Care 2008; 8: 404-412.
  4. Keyrouz SG, Dhar R, Axelrod YK. Call-Fleming syndrome and orgasmic cephalgia. Headache 2008; 48(6): 967-971.
  5. Corry JJ, Dhar R, Murphy T, Diringer MN. Hypothermia for refractory status epilepticus. Neurocrit Care 2008, 9(2): 189-197.
  6. Keyrouz SG, Dhar R, Diringer MN. Variation in osmotic response to sustained mannitol administration. Neurocrit Care 2008, 9(2): 204-209.

Diringer

  1. Dhar R, Diringer MN, The Burden of the Systemic Inflammatory Response Predicts Vasospasm and Outcome after Subarachnoid Hemorrhage, Neurocrit Care. 2008;8(3):404-12
  2. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun N, and Broderick JP, Risk of Thromboembolic Events in Controlled Trials of rFVIIa in Spontaneous Intracerebral Hemorrhage, Stroke, 2008 39(3):850-6.
  3. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage, New Eng J Med, 2008;358:2127-37.
  4. Corry JJ, Dhar R, Diringer MN, Hypothermia for Refractory Status Epilepticus, Neurocrit Care. 2008; 9(2):189-97.
  5. Keyrouz SA, Dhar R and Diringer MN, Variation in osmotic response to sustained mannitol administration, Neurocrit Care. 2008, 2008; 9(2):204-9.

Eisenman

  1. Mennerick S, Lamberta M, Shu HJ, Hogins J, Wang C, Covey DF, Eisenman LN, Zorumski CF, Effects of membrane capacitance of steroids with antagonist properties at GABAA receptors. Biophys J. 2008: 176-185

Fagan

  1. Biomarkers of Alzheimer’s disease. Craig-Schapiro R, Fagan AM, Holtzman DM. Neurobiol Dis. 2008 Oct 28. [Epub ahead of print] PMID: 19010417 [PubMed – as supplied by publisher]Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.
  2. Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8050-4. Epub 2008 Jun 9. PMID: 18541914 [PubMed – indexed for MEDLINE]
  3. Cerebral amyloid-beta protein accumulation with aging in cotton-top tamarins: a model of early Alzheimer’s disease?
    Lemere CA, Oh J, Stanish HA, Peng Y, Pepivani I, Fagan AM, Yamaguchi H, Westmoreland SV, Mansfield KG. Rejuvenation Res. 2008 Apr;11(2):321-32. PMID: 18341428 [PubMed – indexed for MEDLINE]

Fucetola

  1. Hogue, C. W., Fucetola, R., Hershey, T., Freedland, K., Davila-Roman, V., Goate, A. M., and Thompson, R. E. (2008). Risk factors for neurocognitive dysfunction after cardiac surgery in postmenopausal women. Annals of Thoracic Surgery, 86, 511-516.
  2. Naunheim, R. S., Matero, D., and Fucetola, R. (2008). Assessment of patients with mild concussion in the ED. Journal of Head Trauma Rehabilitation, 23(2), 116-122.
  3. Hogue, C. W., Fucetola, R., Hershey, T., Nassief, A., Birge, S. Davila-Roman, V. G., Barzilai, B., Thomas, B., Schechtman, K. B., and Freedland, K. (2008). The role of postoperative neurocognitive dysfunction on quality of life for post-menopausal women six months after cardiac surgery. Anesthesia & Analgesia, 107(1), 21-28.

Galvin

  1. Sevigny JJ, Ryan JM, van Dyck CH, Peng Y, Lines CR, Nessly ML; MK-677 Protocol 30 Study Group. Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial. Neurology. 71:1702-1708,2008.
  2. Johnson DK, Storandt M, Morris JC, Galvin JE. Cognitive profiles in dementia: Alzheimer disease versus nondemented aging. Neurology 71:1783-1789,2008.
  3. Galvin JE, Fu Q, Nguyen JT, Glasheen C, Scharff DP. Psychosocial Determinants of Intention to Screen for Alzheimer Disease. Alzheimer Dement 4:353-360;2008
  4. Fleisher AS, Raman R, Siemers ER, Clark CM, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Shezai AD, Aisen PS, Thal LJ. Phase II trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer’s Disease. Arch Neurol, 65:1031-1038,2008
  5. Galvin JE, Cornblatt B, Newhouse P, Ancoli-Israel, Wesnes K, Williamson D, Zhu Y, Sorra K, Amatniek J. Attention Deficits in Alzheimer’s Disease: Two Head-to-Head Studies of Galantamine and Donepezil. Alz Dis Assoc Disord, 22:30-38, 2008.
  6. Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE. Curcumin inhibits aggregation of -synuclein. Acta Neuropathol. 115:479-489, 2008
  7. Burke WJ, Kumar VB, Pandey N, Franko MW, O’Dell M, Chung HD, Galvin JE. DOPAL, the MAO Metabolite of Dopamine is Responsible for Dopamine Neuron Loss and Triggers -Synuclein Aggregation in vitro. Acta Neuropathologica, 115:193-203,2008

Gurnett

  1. Dobbs MB, Boehm S, Grange DK, Gurnett CA. Case report: congenital knee dislocation in a patient with Larsen syndrome and a novel filamin B mutation. Clin Orthop Relat Res. 2008; Mar6.
  2. Gurnett CA, Veile R, Zempel J, Blackburn L, Lovett M, Bowcock A. Disruption of sodium bicarbonate transporter SLC4A10 in a patient with complex partial epilepsy and mental retardation. Arch Neurol, 2008; 65(4):550-3.
  3. Gurnett CA, Boehm S, Connolly A, Reimschisel T, Dobbs MB. Impact of congenital talipes equinovarus etiology on treatment outcomes, Dev Med Child Neurol, 2008; 50(7):498-502.
  4. Kruse L, Dobbs MB, Gurnett CA. Polygenic threshold model with gender dimorphism in clubfoot inheritance: The Carter effect, J Bone Joint Surg Am. 2008, 90(12):2688-94.
  5. Bassuk AG, Wallace RW, Buhr A, Buller AR, Afawi Z, Shimojo M, Miyata S, Chen S, Gonzalez-Alegre P, , Griesbach HL, Wu S, Nashelsky M, Vladar EK, Antic D, Ferguson PJ, Cirak S, Voit T, Scott MP, Axelrod JD, Gurnett C, Daoud AS, Kivity S, Neufeld MY, Mazarib A, Straussberg R, Walid S, Korczyn AD, Slusarski DC, Berkovic SF, El-Shanti H. A homozygous mutation in human PRICKLE1 causes an autosomal recessive progressive myoclonus-ataxia syndrome, Am J Hum Genet, 2008; 83(5):572-81.
  6. Gurnett CA, Alaee F, Kruse LM, Desruisseau DM, Hecht JT, Wise CA, Bowcock AM, Dobbs MB. Asymmetric lower limb malformations in individuals with homeobox PITX1 gene mutations, Am J Hum Genet, 2008; 83(5):616-22.

Hogan

  1. Hogan RE, Carne RP, Kilpatrick CJ, Cook MJ, Patel A, King L, O’Brien TJ. Hippocampal deformation mapping in MRI-negative PET-positive temporal lobe epilepsy. Journal of Neurology Neurosurgery and Psychiatry. 2008;79:636-640.
  2. Van Raay L, Morris M, Reed RC, Hogan RE, O’Brien TJ, Dedeurwaerdere S. Discordance between valproate plasma levels and seizure suppression in a genetic rat model of absence epilepsy. Proceedings of the Australian Neuroscience Society. 2008:13: 118.
  3. Deduwaerdere S, van Raay L, Morris M, Reed RC, Hogan RE, O’Brien TJ. Relationship of valproate plasma, CSF, and brain pharmacokinetics: Evidence of a direct receptor effect? Neurology. 2008:70(Supl 1):A224.
  4. Hogan RE, Bouilleret V, Liu YR, Wang L, Williams J, Jupp B, Myers D, O’Brien TJ. MRI-based large deformation high dimensional mapping of the hippocampus in rats: development and validation of the technique. Society for Neuroscience meeting, 2008.
  5. van Raay L, Morris M, Reed RC, Hogan RE, O’Brien TJ, Deduwaerdere S. Does intermittent administration of valproate result in better seizure suppression compared to continuous administration in two rat model of epilepsy? Epilepsia 2008:49 (suppl. 7): 108.
  6. Escandon A, Blackburn S, Hogan, R, Dowling J, Eisenman L, Leuthardt E, Rashid S. Outcomes of selective amygdalohippocampectomy versus anterior temporal lobectomy for intractable mesial temporal lobe epilepsy. Epilepsia 2008:49 (suppl. 7): 279.
  7. Hogan RE, Bouilleret V, Liu YR, Wang L, Williams J, Jupp B, Myers D, O’Brien TJ. Development and validation of the technique of MRI-based large deformation high dimensional mapping of the hippocampus in rats. Epilepsia 2008:49 (suppl. 7): 364-365.

Holtzman

  1. Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice.
    Koenigsknecht-Talboo J, Meyer-Luehmann M, Parsadanian M, Garcia-Alloza M, Finn MB, Hyman BT, Bacskai BJ, Holtzman DM.
    J Neurosci. 2008 Dec 24;28(52):14156-64. PMID: 19109498 [PubMed – indexed for MEDLINE]
  2. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
    Han BH, Zhou ML, Abousaleh F, Brendza RP, Dietrich HH, Koenigsknecht-Talboo J, Cirrito JR, Milner E, Holtzman DM, Zipfel GJ.
    J Neurosci. 2008 Dec 10;28(50):13542-50. PMID: 19074028 [PubMed – indexed for MEDLINE]
  3. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. J Clin Invest. 2008 Dec;118(12):4002-13. doi: 10.1172/JCI36663. Epub 2008 Nov 13.
    PMID: 19033669 [PubMed – indexed for MEDLINE]
  4. Biomarkers of Alzheimer’s disease. Craig-Schapiro R, Fagan AM, Holtzman DM. Neurobiol Dis. 2008 Oct 28. [Epub ahead of print]
    PMID: 19010417 [PubMed – as supplied by publisher]
  5. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. J Clin Invest. 2008 Nov 13. [Epub ahead of print] PMID: 19008965 [PubMed – as supplied by publisher]
  6. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells. Yamada K, Hashimoto T, Yabuki C, Nagae Y, Tachikawa M, Strickland DK, Liu Q, Bu G, Basak JM, Holtzman DM, Ohtsuki S, Terasaki T, Iwatsubo T. J Biol Chem. 2008 Dec 12;283(50):34554-62. Epub 2008 Oct 21. PMID: 18940800 [PubMed – indexed for MEDLINE]
  7. Alzheimer’s disease risk variants show association with cerebrospinal fluid amyloid beta. Kauwe JS, Wang J, Mayo K, Morris JC, Fagan AM, Holtzman DM, Goate AM. Neurogenetics. 2009 Feb;10(1):13-7. Epub 2008 Sep 24. PMID: 18813964 [PubMed – in process]
  8. Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer’s disease. Cheng H, Zhou Y, Holtzman DM, Han X.
    Neurobiol Aging. 2008 Aug 30. [Epub ahead of print] PMID: 18762354 [PubMed – as supplied by publisher]
  9. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, Holtzman DM. Science. 2008 Aug 29;321(5893):1221-4. PMID: 18755980 [PubMed – indexed for MEDLINE]
  10. Ceramide is responsible for the failure of compensatory nerve sprouting in apolipoprotein E knock-out mice. Maysinger D, Holmes M, Han X, Epand RM, Pertens E, Foerster A, Barlas C, Holtzman DM, Diamond J. J Neurosci. 2008 Jul 30;28(31):7891-9. PMID: 18667621 [PubMed – indexed for MEDLINE]
  11. Alzheimer’s disease: Moving towards a vaccine. Holtzman DM. Nature. 2008 Jul 24;454(7203):418-20. No abstract available. PMID: 18650906 [PubMed – indexed for MEDLINE]
  12. ApoE promotes the proteolytic degradation of Abeta. Jiang Q, Lee CY, Mandrekar S, Wilkinson B, Cramer P, Zelcer N, Mann K, Lamb B, Willson TM, Collins JL, Richardson JC, Smith JD, Comery TA, Riddell D, Holtzman DM, Tontonoz P, Landreth GE. Neuron. 2008 Jun 12;58(5):681-93. PMID: 18549781 [PubMed – indexed for MEDLINE]
  13. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition.
    Kauwe JS, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Proc Natl Acad Sci U S A. 2008 Jun 10;105(23):8050-4. Epub 2008 Jun 9. PMID: 18541914 [PubMed – indexed for MEDLINE]
  14. Early diffusion-weighted MRI as a predictor of caspase-3 activation after hypoxic-ischemic insult in neonatal rodents.
    Wendland MF, Faustino J, West T, Manabat C, Holtzman DM, Vexler ZS. Stroke. 2008 Jun;39(6):1862-8. Epub 2008 Apr 17. PMID: 18420950 [PubMed – indexed for MEDLINE]
  15. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo.
    Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM. Neuron. 2008 Apr 10;58(1):42-51.
    PMID: 18400162 [PubMed – indexed for MEDLINE]
  16. Active and passive immunotherapy for neurodegenerative disorders. Brody DL, Holtzman DM. Annu Rev Neurosci. 2008;31:175-93. Review. PMID: 18352830 [PubMed – indexed for MEDLINE]
  17. Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer’s disease.
    Meyer-Luehmann M, Spires-Jones TL, Prada C, Garcia-Alloza M, de Calignon A, Rozkalne A, Koenigsknecht-Talboo J, Holtzman DM, Bacskai BJ, Hyman BT. Nature. 2008 Feb 7;451(7179):720-4. PMID: 18256671 [PubMed – indexed for MEDLINE]
  18. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease.
    Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, Jain S, Hirsch-Reinshagen V, Wellington CL, Bales KR, Paul SM, Holtzman DM. J Clin Invest. 2008 Feb;118(2):671-82. PMID: 18202749 [PubMed – indexed for MEDLINE]
  19. Neuropathology for the neuroradiologist: plaques and tangles. Wippold FJ 2nd, Cairns N, Vo K, Holtzman DM, Morris JC. AJNR Am J Neuroradiol. 2008 Jan;29(1):18-22. Epub 2007 Oct 9. Review. PMID: 17925367 [PubMed – indexed for MEDLINE]

Jacquin

  1. Jacquin, M.F., J.J.A. Arends, C. Xiang, L. Shapiro, C.E. Ribak, and Z.-F. Chen. In Drg11 knockout mice,trigeminal cell death is extensive and does not account for failed brainstem patterning. J. Neurosci., 28:3577-85, 2008.
  2. Mosconi, T., T.A. Woolsey and M.F. Jacquin: Active vs. passive touch-induced foci of 2DG label in the developing trigeminal neuraxis. Submitted 6/08.

Larsen

  1. Larsen DP, Butler AC, Roediger HL. “Test-enhanced learning in medical education.” Medical Education 2008;42:955-66.

Lee

  1. Schmidt R.E., Green K.G., Feng D., Dorsey D.A., Parvin C.A., Lee J.M., Xiao Q., Brines, M. Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice. Exp Neurol, 209(1):161-70, 2008.
  2. Daginakatte G.C, Gadzinski A., Emnett R.J., Stark J.L., Gonzales E.R., Yan P., Lee J.-M., Cross A.H., Gutmann D.H., Expression profiling identifies a molecular signature of reactive astrocytes stimulated by cyclic AMP or proinflammatory cytokines, Exp Neurol, 210:261-7, 2008.
  3. Lee J.M., Yan P., Xiao Q., Chen S., Lee K.Y., Hsu C.Y., Xu J., Methylprednisolone protects oligodendrocytes but not neurons following spinal cord injury, J Neurosci, 28(12):3141-9, 2008.
  4. Vetrivel, K.S., Zhang, X., Meckler X., Cheng H., Lee S., Gong P., Lopes K.O., Chen Y., Iwata N., Yin K.-J., Lee J.-M., Parent A.T., Saido T.C., Li Y.-M., Sisodia S.S., Thinakaran G. Evidence that CD147 modulation of Aβ levels is mediated by extracellular degradation of secreted Aβ, J Biol Chem, 283(28):19489-98, 2008.
  5. Lee J.-M., Blennow K., Andreasen N., Laterza O., Modur V., Olander J., Gao F., Ohlendorf M., Ladenson J.H., The Brain Injury Biomarker, VLP-1, is increased in the CSF of Alzheimer’s Disease patients, Clin Chem, 54(10):1617-23, 2008.
  6. Zipfel G.Z., Han H., Ford A., Lee J.-M. Cerebral amyloid angiopathy: Progressive disruption of the neurovascular unit. Stroke, 40(3 Suppl):S16-9, 2008.

Li

  1. Li, M. & Rossi, J. Lentiviral vector delivery of siRNA and shRNA encoding genes into cultured and primary hematopoietic cells. in Gene Therapy Protocols (ed. Le Doux, J.M.) 287-299 (Humana Press, Totowa, NJ, 2008)
  2. MorrisLi Y, Rowland C, Catanese J, Morris J, Lovestone S, O’Donovan MC, Goate A, Owen M, Williams J, Grupe A. SORL1 variants and risk of late-onset Alzheimer’s disease. Neurobiol.Dis 2008; 209:293-296.
  3. Wippold FJ, Cairns N, Vo K, Holtzman D, Morris JC. Neuropathology for the neuroradiologist: plaques and tangles. AJNR 2008; 29:18-22
  4. Roe CM, Xiong C, Grant E, Miller JP, Morris JC. Education and reported onset of symptoms among individuals with Alzheimer’s disease. Arch Neurol 2008; 65:108-111.
  5. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA. Altered neuronal gene expression in brain regions differentially affected by Alzheimer’s Disease: A reference data set. Physiol. Genomics 2008; 33:240-256.
  6. Carpenter BD, Xiong C, Porensky EK, Lee MM, Brown PJ, Coats M, Johnson D, Morris JC. Reaction to a dementia diagnosis in individuals with Alzheimer’s disease and mild cognitive impairment. JAGS 2008; 56:405-412.
  7. Fotenos AF, Mintun MA, Snyder AZ, Morris JC, Buckner RL. Brain volume decline in aging: evidence for a relationship between socioeconomic status, preclinical AD, and reserve. Archives of Neurology, 2008; 65:113-120.
  8. Ott BR, Heindel WC, Papandonatos GD, Festa EK, Davis JD, Daiello LA, Morris JC. A longitudinal study of drivers with Alzheimer’s disease. Neurology 2008; 70:1171-1178.
  9. Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette B, Perlmutter JS, O’Donovan MC, Morris JC, Brayne C, Rubinstein DC, Lovestone S, Thal LJ, Owen MJ, Williams J. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer’s and Parkinson’s disease. Human Molecular Genetics 2008; 17:759-767.
  10. Liang W, Reiman EM, Valla J, Dunckley T, Beach TG, Grover A, Niedzielko TL, Schneider LE, Mastroeni D, Caselli R, Kukull W, Morris JC, Hulette C, Schmechel D, Rogers J, Stephan DA. Alzheimer’s disease is associated with reduced expression of energy metabolism genes in posterior cingulated neurons. PNAS 2008; 105:4441-4446.
  11. Mukherjee O, Wang J, Gitcho M, Chakraverty S, Taylor-Reinwald L, Shears S, Kauwe JSK, Norton J, Levitch D, Bigio EH, Hatanpaa KJ, White CL, Morris JC, Cairns NJ, Goate A. Molecular characterization of novel progranulin (GRN) mutations in frontotemporal dementia. Human Mutation 2008; 29:512-521.
  12. Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot
    PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A. Consortium to Establish a Registry for Alzheimer’s Disease (CERAD): The first twenty years. Alzheimer’s & Dementia 2008; 4:96-109.
  13. Hatanpaa KJ, Bigio EH, Cairns NJ, Womack KB, Weintraub S, Morris JC, Foong C, Xiao G, Hladik C, Mantanona TY, White CL. TAR DNA-binding Protein 42 immunohistochemistry reveals extensive neuritic pathology in FTLD-U: A Midwest-Southwest Consortium for FTLD study. JNEN 2008; 67:271-279.
  14. Xiong C, Tang Y, vanBelle G, Miller JP, Launer LJ, Morris JC. Evaluating the quality of longitudinal statistical applications in original publications on Alzheimer’s disease. Neuroepidemiology 2008; 30:112-119.
  15. Roe CM, Xiong C, Miller JP, Cairns NJ, Morris JC. Interaction of neuritic plaques and education predicts dementia. ADAD 2008; 22:188-193.
  16. St. George-Hyslop PH, Morris JC. (editorial) Will anti-amyloid therapies work for Alzheimer’s disease? Comment, The Lancet 2008; 372:180-182.
  17. Morris JC. Profile: beating dementia through prevention. The Lancet Neurology; 2008; 7:678.
  18. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, Levitch D, Hatanpaa KJ, White CL, Bigio EH, Caselli R, Baker M, Al-Lozi MT, Morris JC, Pestronk A, Rademakers R, Goate AM, Cairns NJ. TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 2008; 63:535-538.
  19. Jarvik L, LaRue A, Blacker D, Gatz M, Kawas C, McArdle JJ, Morris JC, Mortimer JA, Ringman JM, Ercoli L, Freimer N, Gokhman I, Manly JJ, Plassman BL, Rasgon N, Roberts JS, Sunderland T, Swan GE, Wolf P, Zonderman AB. Children of persons with AD: What does the future hold? Alz Dis Assoc Dis 2008; 22:6-20.
  20. Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Ramsey K, Caselli RJ, Kukull WA, McKeel D, Morris JC, Hulette CM, Schmechel D, Reiman EM, Rogers J, Stephan DA. Neuronal gene expression in non-demented individuals with intermediate Alzheimer’s Disease neuropathology. Neurobiology of Aging 2008, in press.
  21. Roe CM, Mintun MA, D’Angelo G, Xiong C, Grant EA, Morris JC. Alzheimer disease and cognitive reserve: Variation of education effect with Carbon 11-labeled Pittsburgh Compound B uptake. Arch Neurol 2008; 65:1467-1471.
  22. Kauwe JSK, Cruchaga C, Mayo K, Fenoglio C, Bertelsen S, Nowotny P, Galimberti D, Scarpini E, Morris JC, Fagan AM, Holtzman DM, Goate AM. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid beta deposition. PNAS 2008; 105:8050-8054.
  23. Johnson DK, Storandt M, Morris JC, Langford ZD, Galvin JE. Cognitive profiles in dementia: Alzheimer disease vs. healthy brain aging. Neurol 2008; 71:1783-1789.

Neil

  1. Zhao L, Kroenke CD, Song J, Piwnica-Worms D, Ackerman JJH, Neil JJ, “Intracellular Water Specific MR of Microbead-adherent Cells: The HeLa Cell Intracellular Water Exchange Lifetime,” NMR Biomed, 21, 159-164 (2008).
  2. Zhao L, Sukstanskii AL, Kroenke CD, Song J, Piwnica-Worms D, Ackerman JJH, Neil JJ, “Intracellular Water Specific MR of Microbead-adherent Cells: HeLa Cell Intracellular Water Diffusion,” Magn Reson Med, 59, 79-84 (2008).
  3. Goodman JA, Ackerman JJH, Neil JJ, “Intracellular Cesium Ion Diffusion in the Rat Brain Decreases Markedly upon Death,” Magn Reson Med, 59, 65-72 (2008).
  4. Mathur AM, Neil JJ, McKinstry RC, Inder TE, “Transport, Monitoring, and Successful Brain MR Imaging in Unsedated Neonates,” Ped Radiol, 38, 260-264 (2008).Neil JJ, “Diffusion imaging concepts for clinicians,” J Magn Reson Imaging, 27, 1-7 (2008).
  5. Lodygensky GA, Inder TE, and Neil JJ, “Application of magnetic resonance imaging in animal models of perinatal hypoxic-ischemic cerebral injury,” Int J Dev Neurosci, 26, 13-25 (2008).

Noetzel

  1. King AA, Noetzel M, White DA, McKinstry RC, DeBaun MR. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell and silent cerebral infarcts. Pediatr Blood Cancer 2008; 50:599-602
  2. Fowler EA, Becker DB, Pilgram TK, Noetzel M, Epstein J, Kane AA. Neurological findings in patients with deformational plagiocephaly. J Child Neurol 2008; 23: 742-747.
  3. Mar S, Noetzel MJ: Gap junction protein 12: “Connexing” the pieces in the puzzle of myelination and leukodystrophy. Neurology 2008; 70: 744-745.

Perlmutter

  1. Videen TO, Campbell MC, Tabbal SD, Karimi M, Hershey T, Perlmutter JS. Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. J Neurosci Methods 168:275-281,2008. PMC2267480
  2. Foster ER, Black KJ, Antenor J, Perlmutter JS, Hershey T. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease. Brain and Cognition 67:1-10,2008.
  3. Antenor-Dorsey JV, Laforest R, Moerlein SM, Videen TO, Perlmutter JS. Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging 35:771-778,2008.
  4. Hershey T, Wu J, Weaver PM, Perantie DC, Karimi M, Tabbal SD, Perlmutter JS. Unilateral vs. bilateral STN DBS effects on working memory and motor function in Parkinson disease. Exp Neurol 211:234-242, 2008. PMC2346537
  5. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire M-H, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett AJ, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study. Neurol. 71:28-34, 2008. PMC2654275.
  6. Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinex M, Hollingworth P, Brayne C, Rubinsztein DC, Cairns NJ, Racette BA, Perlmutter JS, O’Donovan MC, Morris JC, Lovestone S, Thal LJ, Owen MJ, Goate A, Williams J. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer’s and Parkinson’s disease. Hum Mol Genet. 17:759-767, 2008.
  7. Antenor-Dorsey JV, Markham J, Moerlein SM, Videen TO, Perlmutter JS. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-Methyl)Benperidol in humans. Nucl Med Biol. 35:335-341,2008. PMC2390782
  8. Tabbal S, Ushe M, Mink JW, Revilla FJ, Wernle A, Hong M, Karimi M, Perlmutter JS: Unilateral STN stimulation has a measurable ipsilateral effect on rigidity and bradykinesia in Parkinson disease. Exp Neurol 210:402-408,2008. PMC2413293
  9. Hong M, Earhart GM. Rotating treadmill training reduces freezing in Parkinson disease: Preliminary observations. Parkinsonism Relat Disord. 2007 Aug 28; [Epub ahead of print]
  10. McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Saint-Hilaire MH, Massood T, Huskey KW, DeStefano AL, Gillis T, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Huntington CAG repeat size does not modify onset age in familial Parkinson‘s disease: The GenePD Study. Mov Dis.23:1596-1601,2008. PMC2655323
  11. Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS. Cerebral mitochondrial metabolism in early Parkinson disease. J Cereb Blood Flow Metab. 28:1754-60,2008. PMC2597083
  12. Destefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C, Goldwurm S, Pezzoli G, Saint-Hilaire MH, Hendricks AE, Gower A, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH: Replication of association study between ELAVL4 and and Parkinson disease: the GenePD study. Human Genetics June 29, 2008 [Epub ahead of print]
  13. Hong M, Perlmutter JS, Earhart GM. A kinematic and electromyographic analysis of turning in people with Parkinson disease. Neurorehabil Neural Repair. 23;166-176, 2008. PMC2649739
  14. Campbell MC, Karimi M;Weaver P;Wu J; Perantie D;Golchin N; Tabbal; Perlmutter JS, Hershey T. Neural correlates of STN DBS-induced cognitive variability in Parkinson disease. Neuropsychologia 46:3162-9, 2008. PMC2570107
  15. Karimi M, Golchin N, Tabbal S, Hershey T, Videen TO, Wu J, Mink JW, Perlmutter JS: Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease Brain 2008 Aug 12 [Epub ahead of Press].
  16. Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A. LRRK2 gene G1920S mutation and SNPs [haplotypes] in subtypes of Parkinson’s disease. Parkinson Relat Disord. Aug 25,2008 [Epub Ahead of Press].
  17. Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, WIlk JB, Massood T, Huskey KW, Laramie JM, Destegano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corebett A, Nance M, Drasby E, Isaacson S, Burn DJ, Bhinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, BUsella JF, Myers RH. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson’s disease: the GenePD study. BMC Med. 6:32, 2008. PMC2596771

Piccio

  1. McCandelss EE, Piccio L, Woerner BM, Schmidt RE, Rubin JB, Cross AH, Klein RS. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am J Pathol 2008; 1722:799-808.
  2. Piccio L, Stark JL, Cross AH. Chronic Calorie Restriction attenuates Experimental Autoimmune Encephalomyelitis. J Leukoc Biol, 2008; O84(4):940-8.
  3. Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, Rinker II J, Naismith RT, Panina-Bordignon P, Passini N, Galimberti D, Scarpini E, Colonna M, Cross AH. Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain 2008; 131:3081-91.

Racette

  1. Tobin JE, Latourelle JC, Lew MF, Klein C, Suchowersky O, Shill HA, Golbe LI, Mark MH, Growdon JH, Wooten GF, Racette BA, Perlmutter JS, Watts R, Guttman M, Baker KB, Goldwurm S, Pezzoli G, Singer C, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Laramie JM, DeStefano AL, Litvan I, Nicholson G, Corbett A, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Sherman S, Al-hinti J, Drasby E, Nance M, Moller AT, Ostergaard K, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Haplotypes and gene expression implicate the MAPT region for Parkinson disease: The GenePD Study. Neurology 2008 71(1):28-34.
  2. Li Y, Grupe A, Rowland C, Holmans P, Segurado R, Abraham R, Jones L, Catanese J, Ross D, Mayo K, Martinez M, Hollingworth P, Goate A, Cairns NJ, Racette BA, Perlmutter JS, O’Donovan MC, Morris JC, Brayne C, Rubinsztein DC, Lovestone S, Thal LJ, Owen MJ, Williams J. Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer’s and Parkinson’s disease. Hum Mol Genet 2008;17(5):759-67.
  3. Crowner BE and Racette BA. A Prospective Study Examining Remote Effects of Botulinum Toxin A in Children with Cerebral Palsy. Pediatric Neurology 2008; in press.
  4. DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C, Goldwurm S, Pezzoli G, Saint-Hilaire MH, Hendricks AE, Gower A, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet 2008;124(1):95-9.
  5. Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Laramie JM, DeStefano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson’s disease: the GenePD study. BMC Med;2008,65(12):1582-9.

Roe

  1. Roe CM, Mintun MA, D’Angelo G, Xiong C, Grant E, Morris JC. Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labled Pittsburgh Compound B uptake. Archives of Neurology 2008;65:1467-1471.
  2. Roe CM, Xiong C, Miller JP, Cairns NJ, Morris JC. Interaction of neuritic plaques and education predicts dementia. Alzheimer Disease and Associated Disorders 2008;22:188-193.
  3. Behrens MI, Roe CM, Morris JC. Inverse association between cancer and dementia of the Alzheimers type. In: von Bernhardi R., Inestrosa N. (Eds), Neurodegenerative Diseases: From Molecular Concepts to Therapeutic Targets. Nova Editorials, Publishers, Inc. New York, USA, 2008, pp. 111-120.
  4. Roe CM, Xiong C, Grant E, Miller JP, Morris JC. Education and reported onset of symptoms among individuals with Alzheimer’s disease. Archives of Neurology 2008;65:108-111.

Schlaggar

  1. Dosenbach, N.U., Miezin, F.M., Burgund, E.D., Schlaggar, B.L., Petersen, S.E. (2008) Timing and control-related networks dissociated by mixed blocked/event-related fMRI. Trends in Cognitive Science, 12(3):99-105.
  2. Fair, D.A., Dosenbach, N.U.F., Church, J.A., Cohen, A.L., Miezin, F.M., Barch, D., Petersen, S.E., Schlaggar, B.L. (2008) The Maturing Architecture of the Brain’s Default Network. Proc Nat Acad Sci., 105:4028-4032.
  3. Church, J.A., Coalson, R.S., Lugar, H.M., Petersen, S.E., Schlaggar, B.L. (2008) A developmental fMRI study of reading and repetition reveals changes in phonological and visual mechanisms over age. Cerebral Cortex, 18:2054-2065.
  4. Cohen L.A., Fair, D.A., Dosenbach, N.U.F., Miezin, F.M., Dierker, D., Van Essen, D.C., Schlaggar, B.L., Petersen, S.E. (2008) Defining Functional Areas in Individual Human Brains using Resting Functional Connectivity MRI. NeuroImage, 41:45-57.
  5. Church, J.A., Fair, D.A., Dosenbach. N.U.F., Cohen, A.L., Miezin, F.M., Petersen, S.E., Schlaggar, B.L. (2008) Control networks in pediatric Tourette syndrome show immature and anomalous patterns of functional connectivity. Brain, Oct 24. E-Pub ahead of print.
  6. Becker, D.B., Coalson, R.S., Sachanandani, N.S., Fair, D.A., Lugar, H.M., Kirchner, L.E., Schlaggar, B.L., Kane, A.A (2008). Functional neuroanatomy of lexical processing in children with cleft lip and palate. Plast Reconstr Surg. 122:1371-82.

Schwarze

  1. MacDonald, C.L., Schwarze, N., Vaishnavi, S.N., Epstein, A.A., Snyder,A.Z., Raichle, M.E., Shimony, J.S., Brody, D.L. Verbal memory deficit following traumatic brain injury: assessment using advanced MRI methods. Neurology, 71, October 7, 2008, 1199-1201.
  2. Weaver, T.L., Turner, P.K., Schwarze, N.J., Thayer, C.A., and Carter-Sand, S. (2007). An exploratory examination of the meaning of residual injuries from intimate partner violence. Women & Health, 45 (3), 85-102.

Shulman

  1. Sestieri C, Sylvester CM, Jack AI, d`Avossa G, Shulman GL, Corbetta M, Independence of anticipatory signals for spatial attention from number of non-target stimuli in the visual field. Journal of Neurophysiology 2008: 100: 829-838.
  2. Bressler SL, Tang W, Sylvester CM, Shulman GL, Corbetta M, Top-down control of human visual cortex by frontal and parietal cortex in anticipatory visual spatial attention. Journal of Neuroscience 2008: 28: 10056-10061.
  3. Corbetta M, Patel G, Shulman GL, The reorienting system of the human brain: from environment to theory of mind. Neuron 2008: 58: 306-324.
  4. Sylvester CM, Jack AI, Corbetta M, Shulman GL, Anticipatory suppression of non-attended locations in visual cortex marks target location and predicts perception. Journal of Neuroscience 2008: 28: 6549-6556.

Thio

  1. Xu L, Rensing N, Yang X-F, Zhang HX, Thio LL, Rothman SM, Weisenfeld AE, Wong M, Yamada KA. Leptin inhibits 4-aminopyridine and pentylenetetrazole induced seizures and AMPAR mediated synaptic transmission. Journal of Clinical Investigation 2008; 118: 272-280.
  2. Erbayat-Altay E, Yamada KA, Wong M, Thio LL. Increased severity of pentylenetetrazol induced seizures in leptin deficient ob/ob mice. Neuroscience Letters 2008; 433: 82-86.

Van Stavern

  1. Van Stavern GP, Van Stavern RD. Stroke and visual loss. Expert Rev Ophthalmol. 2008:3(5);529-541.

Videen

  1. Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer PE: Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 2008;57:470-5.
  2. Videen TO, Campbell MC, Tabbal SD, Karimi M, Hershey T, Perlmutter JS: Validation of a fiducial-based atlas localization method for deep brain stimulation contacts in the area of the subthalamic nucleus. J Neurosci Meth 2008;168:275-81.
  3. Antenor JV, Laforest R, Moerlein SM, Videen TO, Perlmutter JS: Radiation dosimetry of N-([11C]methyl)benperidol as determined by whole-body PET imaging of primates. Eur J Nucl Med Mol Imaging 2008; 35:771-8.
  4. Antenor-Dorsey JA, Markham J, Moerlein SM, Videen TO, Perlmutter JS: Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans. Nucl Med Biol 2008; 35:335-41.
  5. Powers WJ, Videen TO, Markham J, Black KJ, Golchin N, Perlmutter JS: Cerebral mitochondrial metabolism in early Parkinson disease. J Cereb Blood Flow Metab 2008; 28:1754-60.
  6. Karimi M, Golchin N, Tabbal SD, Hershey T, Videen TO, Wu J, Usche JW, Revilla FJ, Hartlein JM, Wernle AR, Mink JW, Perlmutter JS. Subthalamic nucleus stimulation-induced regional blood flow responses correlate with improvement of motor signs in Parkinson disease. Brain 2008; 131:2710-9.

Wong

  1. Xu L, Rensing N, Yang XF, Zhang HX, Thio LL, Rothman SM, Weisenfeld AE, Wong M, Yamada KA. Leptin inhibits 4-aminopyridine- and penetyelentetrazole-induced seizures and AMPAR-mediated synaptic transmission in rodents. J Clin Investigation 2008; 118:272-280. PMID: 18097472
  2. Erbayat-Altay E, Yamada KA, Wong M, Thio LL. Increased severity of pentylenetetrazol induced seizures in leptin deficient ob/ob mice. Neurosci Lett 2008; 433;82-86. PMID: 18241989
  3. Zeng LH, Xu L, Gutmann DH, Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008; 63:444-453. PMID: 18389497
  4. Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development. Epilepsia 2008,;49:8-21. PMID: 17727667
  5. Wong M. Stabilizing dendritic structure as a novel therapeutic approach for epilepsy. Expert Rev Neurotherapeutics 2008; 8:907-915. PMID: 18505356

Yamada

  1. Xu, L, Rensing, N, Yang, X-F, Zhang, HX, Thio, LL, Rothman, SM, Weisenfeld, AE, Wong, M, Yamada, KA: Leptin inhibits 4-Aminopyridine and Pentylenetetrazole induced seizures and AMPAR mediated synaptic transmission, Journal of Clinical Investigation, 2008, 118: 272-280.
  2. Erbayat-Altay, E, Yamada, KA, Wong, M, Thio, LL: Increased severity of pentylenetetrazol induced seizures in leptin deficient ob/ob mice, Neuroscience Letters, 2008, 433: 82-86.
  3. Farr, SA, Yamada, KA, Butterfield, DA, Abdul, HM, Xu, L, Miller, NE, Banks, WA, Morley, JE: Obesity and Hypertriglyceridemia Produce Cognitive Impairment, Endocrinology, 2008, 149: 2628-2636.

Zazulia

  1. Zazulia AR (2008) Hydrocephalus in ICH: what do we really know? Neurocritical Care, 8:233-4.
  2. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, FAST Trial Investigators (2008) Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med, 358:2127-37.

Zempel

  1. Shah, DK, Mackay, MT, Lavery S, Watson, S, Harvey, AS, Zempel, J, Mathur, A, Inder, TE, Accuracy of bedside electroencephalographic monitoring in comparison with simultaneous continuous conventional electroencephalography for seizure detection in term infants. 2008 Pediatrics 121(6): 1146-54
  2. Gurnett, CA, R Veile, Zempel, J, Blackburn, Lovett, M, Bowcock, A, Disruption of sodium bicarbonate transporter SLC4A10 in a patient with complex partial epilepsy and mental retardation. 2008 Arch Neurol 65(4): 550-3.
  3. Johnston, JM, Vaishnavi, SN. Smyth, MD. Zhang, D, He, BJ, Zempel, JM, Shimony, JS, Snyder, AZ, Raichle, ME, Loss of resting interhemispheric functional connectivity after complete section of the corpus callosum. 2008. J Neurosci 28(25): 6453-8.
  4. Mathur, A.M, LD Morris, Teteh, F, Inder, TE, Zempel, J Utility of Prolonged Bedside Amplitude-Integrated Encephalogram in Encephalopathic Infants. 2008 Am J Perinatol. Nov;25(10):611-5. Epub 2008 Oct 7.
  5. He, BJ, Snyder, AZ, Zempel, JM, Smyth, MD, Raichle, ME, Electrophysiological correlates of the brain’s intrinsic large-scale functional architecture 2008 Proc Natl Acad Sci U S A 105(41): 16039-44.